
Onyx @ Union Square: Shankar Musunuri, Ocugen
What if the key to curing blindness wasn't targeting individual genes, but entire genetic networks?
What if the key to curing blindness wasn't targeting individual genes, but entire genetic networks?
Lexicon's latest drug for obesity and weight management has a novel mechanism and is backed by Novo Nordisk.
Allucent are helping small- to mid-sized biotechs stay nimble.
Ever thought a probiotic could help manage blood sugar by stimulating GLP-1?
Can this man bring down the cost of some of the most expensive and hope-inspiring new therapies on the market?
Blood tests for cancer are here, and Guardant Health is leading the charge.